10-Q Filing

HealthLynked Corp CIK: 1680139 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001213900-19-015900`
Period End Date	20190630
Filing Date	20190814
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	hlyk-20190630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 88 Cash Flow Statement 110 Stockholders Equity 49

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, net of allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$703.43K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$752.17K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$50.01K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$135.78K	USD	Point-in-time
Goodwill and intangible assets, net of accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.77K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$125.74K	USD	Point-in-time
Goodwill and intangible assets, net of accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	-	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$38.23K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount	`DebtInstrumentUnamortizedDiscountCurrent`	$386.47K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of June 30, 2019 and December 31, 2018, respectively	`AccountsReceivableNetCurrent`	$114.88K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount	`DebtInstrumentUnamortizedDiscountCurrent`	$722.95K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of June 30, 2019 and December 31, 2018, respectively	`AccountsReceivableNetCurrent`	$124.09K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$93.58K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$28.54K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$32.02K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	101.07M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	85.18M	shares	Point-in-time
Deferred offering costs	`DeferredOfferingCosts`	$96.02K	USD	Point-in-time
Deferred offering costs	`DeferredOfferingCosts`	$44.81K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	85.18M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$375.23K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	101.07M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$420.24K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $703,429 and $752,173 as of June 30, 2019 and December 31, 2018, respectively	`PropertyPlantAndEquipmentNet`	$42.60K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $703,429 and $752,173 as of June 30, 2019 and December 31, 2018, respectively	`PropertyPlantAndEquipmentNet`	$553.92K	USD	Point-in-time
Common stock issuable, par value	`CommonStockIssuableIssuePrice`	$0.00	USD	Point-in-time
Common stock issuable, par value	`CommonStockIssuableIssuePrice`	$0.00	USD	Point-in-time
Goodwill and intangible assets, net of accumulated amortization of $1,775 and $0 as of June 30, 2019 and December 31, 2018, respectively	`IntangibleAssetsNetIncludingGoodwill`	-	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	562,726.00	shares	Point-in-time
Goodwill and intangible assets, net of accumulated amortization of $1,775 and $0 as of June 30, 2019 and December 31, 2018, respectively	`IntangibleAssetsNetIncludingGoodwill`	$1.34M	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	114,080.00	shares	Point-in-time
ROU lease assets and deposits	`LeaseAssetsNonCurrent`	$9.54K	USD	Point-in-time
ROU lease assets and deposits	`LeaseAssetsNonCurrent`	$442.45K	USD	Point-in-time
Total Assets	`Assets`	$2.76M	USD	Point-in-time
Total Assets	`Assets`	$427.36K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$394.33K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$514.37K	USD	Point-in-time
Capital lease, current portion	`CapitalLeaseObligationsCurrent`	-	USD	Point-in-time
Capital lease, current portion	`CapitalLeaseObligationsCurrent`	$19.88K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$306.27K	USD	Point-in-time
Due to related party, current portion	`DueToRelatedPartiesCurrent`	$429.72K	USD	Point-in-time
Due to related party, current portion	`DueToRelatedPartiesCurrent`	$463.17K	USD	Point-in-time
Notes payable to related party, current portion	`NotesPayableRelatedPartiesClassifiedCurrent`	$672.47K	USD	Point-in-time
Notes payable to related party, current portion	`NotesPayableRelatedPartiesClassifiedCurrent`	$684.59K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $722,954 and $386,473 as of June 30, 2019 and December 31, 2018, respectively	`ConvertibleDebtCurrent`	$1.23M	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $722,954 and $386,473 as of June 30, 2019 and December 31, 2018, respectively	`ConvertibleDebtCurrent`	$1.04M	USD	Point-in-time
Contingent acquisition consideration	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$500.00K	USD	Point-in-time
Derivative financial instruments	`DerivativeInstrumentsAndHedgesLiabilities`	$800.44K	USD	Point-in-time
Derivative financial instruments	`DerivativeInstrumentsAndHedgesLiabilities`	$632.61K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$4.33M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$3.36M	USD	Point-in-time
Capital leases, long-term portion	`CapitalLeaseObligationsNoncurrent`	$3.06K	USD	Point-in-time
Capital leases, long-term portion	`CapitalLeaseObligationsNoncurrent`	-	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$125.69K	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.36M	USD	Point-in-time
Total Liabilities	`Liabilities`	$4.46M	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 101,068,541 and 85,178,902 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$10.11K	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 101,068,541 and 85,178,902 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$8.52K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 562,726 and 114,080 shares as of June 30, 2019 and December 31, 2018, respectively	`CommonStockIssuableValue`	$105.35K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 562,726 and 114,080 shares as of June 30, 2019 and December 31, 2018, respectively	`CommonStockIssuableValue`	$26.14K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$7.53M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$10.63M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-10.50M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-12.44M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-2.72M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-3.30M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-2.05M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-2.93M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-1.70M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-2.48M	USD	Point-in-time
Total Liabilities and Shareholders' Deficit	`LiabilitiesAndStockholdersEquity`	$2.76M	USD	Point-in-time
Total Liabilities and Shareholders' Deficit	`LiabilitiesAndStockholdersEquity`	$427.36K	USD	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.67M	USD	2 Qtrs
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.21M	USD	2 Qtrs
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.21M	USD	1 Quarter
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$566.32K	USD	1 Quarter
Cost of services	`CostOfGoodsAndServicesSold`	-	USD	1 Quarter
Cost of services	`CostOfGoodsAndServicesSold`	$321.60K	USD	2 Qtrs
Cost of services	`CostOfGoodsAndServicesSold`	$321.60K	USD	1 Quarter
Cost of services	`CostOfGoodsAndServicesSold`	-	USD	2 Qtrs
Gross profit	`GrossProfit`	$886.79K	USD	1 Quarter
Gross profit	`GrossProfit`	$1.35M	USD	2 Qtrs
Gross profit	`GrossProfit`	$1.21M	USD	2 Qtrs
Gross profit	`GrossProfit`	$566.32K	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$1.18M	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$618.14K	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$767.82K	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$1.30M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.13M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.55M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$795.45K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$552.58K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$21.71K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$23.36K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$12.06K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$6.03K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$2.87M	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$1.18M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$1.58M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$2.32M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.52M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.11M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-698.19K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-610.43K	USD	1 Quarter
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$72.44K	USD	1 Quarter
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$16.86K	USD	1 Quarter
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-308.36K	USD	2 Qtrs
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-67.36K	USD	2 Qtrs
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-60.11K	USD	2 Qtrs
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-30.41K	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-83.40K	USD	2 Qtrs
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-25.45K	USD	1 Quarter
Financing cost	`AmortizationOfFinancingCosts`	$440.50K	USD	2 Qtrs
Financing cost	`AmortizationOfFinancingCosts`	$248.44K	USD	1 Quarter
Financing cost	`AmortizationOfFinancingCosts`	$87.33K	USD	1 Quarter
Financing cost	`AmortizationOfFinancingCosts`	$121.23K	USD	2 Qtrs
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-399.40K	USD	2 Qtrs
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-479.00K	USD	2 Qtrs
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-244.56K	USD	1 Quarter
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-299.61K	USD	1 Quarter
Change in fair value of derivative financial instrument	`GainLossOnDerivativeInstrumentsNetPretax`	$415.51K	USD	2 Qtrs
Change in fair value of derivative financial instrument	`GainLossOnDerivativeInstrumentsNetPretax`	$52.79K	USD	1 Quarter
Change in fair value of derivative financial instrument	`GainLossOnDerivativeInstrumentsNetPretax`	$38.16K	USD	2 Qtrs
Change in fair value of derivative financial instrument	`GainLossOnDerivativeInstrumentsNetPretax`	$223.88K	USD	1 Quarter
Interest expense	`InterestExpense`	$91.35K	USD	2 Qtrs
Interest expense	`InterestExpense`	$106.67K	USD	2 Qtrs
Interest expense	`InterestExpense`	$51.01K	USD	1 Quarter
Interest expense	`InterestExpense`	$60.34K	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-418.85K	USD	2 Qtrs
Total other expenses	`NonoperatingIncomeExpense`	$-499.81K	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-181.38K	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-1.28M	USD	2 Qtrs
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.39M	USD	2 Qtrs
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-879.57K	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.94M	USD	2 Qtrs
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.11M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.11M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.06M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-879.57K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.28M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.03	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.02	USD	2 Qtrs
Fully diluted	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Fully diluted	`EarningsPerShareDiluted`	$-0.03	USD	2 Qtrs
Fully diluted	`EarningsPerShareDiluted`	$-0.02	USD	2 Qtrs
Fully diluted	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	98.50M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	75.87M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	74.40M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	93.53M	shares	2 Qtrs
Fully diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	98.50M	shares	1 Quarter
Fully diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	75.87M	shares	1 Quarter
Fully diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	93.53M	shares	2 Qtrs
Fully diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.40M	shares	2 Qtrs

Cash Flow Statement 110 line items

Line Item	Tag	Value	Unit	Period
Depreciation	`DepreciationAndAmortization`	$21.71K	USD	1 Quarter
Depreciation	`DepreciationAndAmortization`	$23.36K	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$12.06K	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$6.03K	USD	1 Quarter
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$97.29K	USD	2 Qtrs
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$317.29K	USD	2 Qtrs
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-399.40K	USD	2 Qtrs
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-479.00K	USD	2 Qtrs
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-244.56K	USD	1 Quarter
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-299.61K	USD	1 Quarter
Financing cost	`AmortizationOfFinancingCosts`	$440.50K	USD	2 Qtrs
Financing cost	`AmortizationOfFinancingCosts`	$248.44K	USD	1 Quarter
Financing cost	`AmortizationOfFinancingCosts`	$87.33K	USD	1 Quarter
Financing cost	`AmortizationOfFinancingCosts`	$121.23K	USD	2 Qtrs
Change in fair value of derivative financial instrument	`ChangeInFairValueOfDerivativeFinancialInstrument`	$415.51K	USD	2 Qtrs
Change in fair value of derivative financial instrument	`ChangeInFairValueOfDerivativeFinancialInstrument`	$52.79K	USD	1 Quarter
Change in fair value of derivative financial instrument	`ChangeInFairValueOfDerivativeFinancialInstrument`	$38.16K	USD	2 Qtrs
Change in fair value of derivative financial instrument	`ChangeInFairValueOfDerivativeFinancialInstrument`	$223.88K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$72.44K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$16.86K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-308.36K	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-67.36K	USD	2 Qtrs
Change in fair value of debt	`NoncashExpense`	$25.45K	USD	1 Quarter
Change in fair value of debt	`NoncashExpense`	$30.41K	USD	1 Quarter
Change in fair value of debt	`NoncashExpense`	$83.40K	USD	2 Qtrs
Change in fair value of debt	`NoncashExpense`	$60.11K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$9.21K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$28.50K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$21.47K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	-	USD	2 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$9.38K	USD	2 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$183.88K	USD	2 Qtrs
ROU lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	-	USD	2 Qtrs
ROU lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$133.05K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$133.27K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$45.34K	USD	2 Qtrs
Lease liability	`IncreaseDecreaseInLeaseLiability`	$128.08K	USD	2 Qtrs
Lease liability	`IncreaseDecreaseInLeaseLiability`	-	USD	2 Qtrs
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$32.61K	USD	2 Qtrs
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$33.49K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.16M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.22M	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.30K	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$201.00	USD	2 Qtrs
Acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$465.00K	USD	2 Qtrs
Acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-201.00	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-469.30K	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$645.50K	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$994.27K	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$200.00	USD	2 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$805.50K	USD	2 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$1.02M	USD	2 Qtrs
Repayment of convertible notes, including prepayment premium	`RepaymentsOfConvertibleDebt`	$284.68K	USD	2 Qtrs
Repayment of convertible notes, including prepayment premium	`RepaymentsOfConvertibleDebt`	$404.42K	USD	2 Qtrs
Proceeds from related party loans	`ProceedsFromRelatedPartyDebt`	$101.45K	USD	2 Qtrs
Proceeds from related party loans	`ProceedsFromRelatedPartyDebt`	-	USD	2 Qtrs
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	-	USD	2 Qtrs
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	$9.00K	USD	2 Qtrs
Proceeds from notes payable and bank loans	`ProceedsFromBankDebt`	$73.50K	USD	2 Qtrs
Proceeds from notes payable and bank loans	`ProceedsFromBankDebt`	-	USD	2 Qtrs
Repayment of notes payable and bank loans	`RepaymentsOfBankDebt`	-	USD	2 Qtrs
Repayment of notes payable and bank loans	`RepaymentsOfBankDebt`	$113.26K	USD	2 Qtrs
Payments on capital leases	`RepaymentsOfDebtAndCapitalLeaseObligations`	-	USD	2 Qtrs
Payments on capital leases	`RepaymentsOfDebtAndCapitalLeaseObligations`	$7.64K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.21M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.62M	USD	2 Qtrs
Net decrease in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-10.04K	USD	2 Qtrs
Net decrease in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-11.78K	USD	2 Qtrs
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$50.01K	USD	Point-in-time
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$135.78K	USD	Point-in-time
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$125.74K	USD	Point-in-time
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$38.23K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$50.01K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$135.78K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$125.74K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$38.23K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$15.59K	USD	2 Qtrs
Cash paid during the period for interest	`InterestPaidNet`	$9.98K	USD	2 Qtrs
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	2 Qtrs
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	$1.25M	USD	2 Qtrs
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	$804.06K	USD	2 Qtrs
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$25.00	USD	2 Qtrs
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$54.00	USD	2 Qtrs
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	$54.26K	USD	2 Qtrs
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	$94.84K	USD	2 Qtrs
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	-	USD	2 Qtrs
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$673.99K	USD	2 Qtrs
Fair value of common shares issued with convertible notes payable	`Fairvalueofcommonsharesissuedwithconvertiblenotespayable`	$17.18K	USD	2 Qtrs
Fair value of common shares issued with convertible notes payable	`Fairvalueofcommonsharesissuedwithconvertiblenotespayable`	-	USD	2 Qtrs
Cashless exercise of options and warrants	`Cashlessexerciseofwarrants`	-	USD	2 Qtrs
Cashless exercise of options and warrants	`Cashlessexerciseofwarrants`	$221.00	USD	2 Qtrs
Adoption of lease obligation and ROU asset	`AdoptionOfLeaseObligationAndROUAsset`	-	USD	2 Qtrs
Adoption of lease obligation and ROU asset	`AdoptionOfLeaseObligationAndROUAsset`	$560.05K	USD	2 Qtrs
Fair value of shares issued as acquisition consideration	`StockIssued1`	$1.00M	USD	2 Qtrs
Fair value of shares issued as acquisition consideration	`StockIssued1`	-	USD	2 Qtrs
Value of contingent acquisition consideration	`ContingentAcquisitionConsiderationValue`	-	USD	2 Qtrs
Value of contingent acquisition consideration	`ContingentAcquisitionConsiderationValue`	$500.00K	USD	2 Qtrs
Fair value of warrants issued to extend maturity date of convertible notes payable	`FairValueOfWarrantsIssuedToExtendMaturityDateOfConvertibleNotesPayable`	-	USD	2 Qtrs
Fair value of warrants issued to extend maturity date of convertible notes payable	`FairValueOfWarrantsIssuedToExtendMaturityDateOfConvertibleNotesPayable`	$10.20K	USD	2 Qtrs
Fair value of warrants issued to extend related party notes payable	`FairValueOfWarrantsIssuedPursuantToAmendedInvestmentAgreement`	-	USD	2 Qtrs
Fair value of warrants issued to extend related party notes payable	`FairValueOfWarrantsIssuedPursuantToAmendedInvestmentAgreement`	$337.47K	USD	2 Qtrs
Derivative liabilities written off with repayment of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithRepaymentOfConvertibleNotesPayable`	$216.64K	USD	2 Qtrs
Derivative liabilities written off with repayment of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithRepaymentOfConvertibleNotesPayable`	$288.57K	USD	2 Qtrs
Derivative liabilities written off with conversion of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithConversionOfConvertibleNotesPayable`	$267.81K	USD	2 Qtrs
Derivative liabilities written off with conversion of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithConversionOfConvertibleNotesPayable`	-	USD	2 Qtrs
Fair value of warrants allocated to proceeds of fixed convertible notes payable	`FairValueOfWarrantsAllocatedToProceedsOfFixedConvertibleNotesPayable`	-	USD	2 Qtrs
Fair value of warrants allocated to proceeds of fixed convertible notes payable	`FairValueOfWarrantsAllocatedToProceedsOfFixedConvertibleNotesPayable`	$225.32K	USD	2 Qtrs

Stockholders Equity 49 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-2.72M	USD	Point-in-time
Balance	`StockholdersEquity`	$-3.30M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.93M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.70M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.48M	USD	Point-in-time
Acquisition of Hughes Center for Functional Medicine	`StockIssuedDuringPeriodValueAcquisitions`	$1.00M	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$694.16K	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$145.46K	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$365.87K	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$133.61K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`AdjustmentsToAdditionalPaindInCapitalCommonStock`	$117.96K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`AdjustmentsToAdditionalPaindInCapitalCommonStock`	$139.07K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`AdjustmentsToAdditionalPaindInCapitalCommonStock`	$15.58K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`AdjustmentsToAdditionalPaindInCapitalCommonStock`	$28.07K	USD	1 Quarter
Fair value of warrants allocated to proceeds of convertible notes payable	`FairValueOfWarrantsAllocatedToProceedsOfConvertibleNotesPayable`	$225.32K	USD	1 Quarter
Fair value of warrants issued to extend related party notes payable	`FairValueOfWarrantsIssuedToExtendRelatedPartyNotesPayable`	$337.47K	USD	1 Quarter
Fair value of warrants issued to extend related party notes payable	`FairValueOfWarrantsIssuedToExtendRelatedPartyNotesPayable`	-	USD	1 Quarter
Fair value of warrants issued to extend convertible notes payable	`FairValueOfWarrantsIssuedToExtendConvertibleNotesPayable`	-	USD	1 Quarter
Fair value of warrants issued to extend convertible notes payable	`FairValueOfWarrantsIssuedToExtendConvertibleNotesPayable`	$10.20K	USD	1 Quarter
Shares issued with convertible notes payable	`Sharesissuedwithconvertiblenotespayable`	$12.50K	USD	1 Quarter
Shares issued with convertible notes payable	`Sharesissuedwithconvertiblenotespayable`	$4.68K	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$54.26K	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$115.12K	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	-	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$535.23K	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$138.76K	USD	1 Quarter
Consultant fees payable with common shares and warrants	`StockToBeIssuedForConsultantFees`	$64.35K	USD	1 Quarter
Consultant fees payable with common shares and warrants	`StockToBeIssuedForConsultantFees`	$22.07K	USD	1 Quarter
Consultant fees payable with common shares and warrants	`StockToBeIssuedForConsultantFees`	$5.28K	USD	1 Quarter
Consultant fees payable with common shares and warrants	`StockToBeIssuedForConsultantFees`	$26.84K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$61.23K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$5.58K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$59.40K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$6.03K	USD	1 Quarter
Exercise of stock warrants	`Exerciseofwarrants`	-	USD	1 Quarter
Exercise of stock warrants	`Exerciseofwarrants`	$200.00	USD	1 Quarter
Exercise of stock options	`ExerciseOfStockOptionsValue`	-	USD	1 Quarter
Exercise of stock options	`ExerciseOfStockOptionsValue`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.11M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.06M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-879.57K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.28M	USD	1 Quarter
Balance	`StockholdersEquity`	$-2.72M	USD	Point-in-time
Balance	`StockholdersEquity`	$-3.30M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.93M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.70M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.48M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.